Mistry described Scp776 as a “designer drug.” She explained that IGF-1 receptors are abundant throughout the body, and IGF-1 ...
Although the goal for NIHSS completion rate was not met, we believe the project was successful. The NIHSS has been integrated successfully into standard nursing practice in assessments of acute stroke ...
If approved, the targeted IGF-1 fusion protein would become the only treatment available for late-window stroke patients ...